GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/14/2026 7:01:21 AM | View | Financials | Earnings | WIRE | 2Q 2026 | Assets $10,984,777 | EPS -$0.53 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/13/2026 4:16:32 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $10,984,777 | EPS -$0.53 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/12/2026 7:03:19 AM | View | Financials | Earnings | WIRE | 1Q 2026 | Assets $9,539,952 | EPS -$0.62 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/11/2026 4:12:42 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $9,539,952 | EPS -$0.62 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/13/2026 7:02:07 AM | View | Financials | Earnings | WIRE | Y 2025 | Assets $7,689,535 | EPS -$0.31 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/12/2026 4:14:45 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $7,689,535 | EPS -$5.32 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/12/2025 7:14:06 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $6,105,211 | EPS -$1.23 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/12/2025 7:01:48 AM | View | Financials | Earnings | WIRE | 3Q 2025 | Assets $6,105,211 | EPS -$1.23 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/12/2025 7:02:46 AM | View | Financials | Earnings | WIRE | 2Q 2025 | Assets $6,157,858 | EPS -$1.89 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/11/2025 4:14:37 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $6,157,858 | EPS -$1.89 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/5/2025 9:20:04 AM | View | Proxy | SEC | Y 2024 | ||||||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/29/2025 4:08:57 PM | View | Proxy | SEC | Y 2024 | ||||||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/13/2025 7:14:13 AM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $4,805,461 | EPS -$0.11 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/12/2025 4:13:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $4,805,461 | EPS -$0.11 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/18/2025 7:13:39 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $3,857,963 | EPS -$0.16 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/17/2025 4:13:05 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $3,857,963 | EPS -$0.87 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/13/2024 7:06:56 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $5,982,759 | EPS -$0.17 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/12/2024 4:23:45 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $5,982,759 | EPS -$0.17 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/9/2024 7:13:58 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $6,580,392 | EPS -$0.26 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/8/2024 4:16:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $6,580,392 | EPS -$0.26 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/15/2024 7:14:29 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $9,108,834 | EPS -$0.28 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/14/2024 4:17:55 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $9,108,834 | EPS -$0.28 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 4/29/2024 4:08:07 PM | View | Proxy | SEC | Y 2023 | ||||||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/18/2024 4:16:18 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $7,709,123 | EPS -$0.38 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/15/2024 4:20:57 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $7,709,123 | EPS -$1.15 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/14/2023 4:38:51 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $7,158,051 | EPS -$0.24 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/13/2023 4:27:17 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $7,158,051 | EPS -$0.24 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/14/2023 7:11:39 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $9,235,777 | EPS -$0.28 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/11/2023 4:15:31 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $9,235,777 | EPS -$0.28 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/12/2023 7:11:02 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $7,385,421 | EPS -$0.25 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/12/2023 7:01:20 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $7,385,421 | EPS -$0.25 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 4/27/2023 4:15:30 PM | View | Proxy | SEC | Y 2022 | ||||||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/16/2023 7:23:36 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $9,376,706 | EPS -$0.28 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/15/2023 5:39:58 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $9,376,706 | EPS -$1.12 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/14/2022 7:13:28 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $10,945,148 | EPS -$0.32 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/10/2022 4:27:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $10,945,148 | EPS -$0.32 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/15/2022 4:23:43 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $9,259,300 | EPS -$0.26 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/12/2022 4:24:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $9,259,300 | EPS -$0.26 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/11/2022 7:12:39 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $11,322,300 | EPS -$0.26 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 5/10/2022 4:18:49 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $11,322,300 | EPS -$0.26 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 4/25/2022 4:08:43 PM | View | Proxy | SEC | Y 2021 | ||||||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/17/2022 7:17:44 AM | View | Financials | Earnings | SEC | Y 2021 | Assets $13,254,150 | EPS -$0.22 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 3/16/2022 4:11:09 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $13,254,150 | EPS -$1.49 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/16/2021 6:11:55 AM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $14,989,628 | EPS -$0.46 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 11/12/2021 4:21:06 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $14,989,628 | EPS -$0.46 | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/16/2021 4:16:02 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $17,440,145 | EPS -$0.57 | Export Earnings Model | ||
| Acurx Pharmaceuticals, Inc. (ACXP) | 8/13/2021 4:12:04 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $17,440,145 | EPS -$0.57 |